title: Sarcoidosis: an underestimated and potentially severe side effect of anti-TNF-alpha therapy.
authors.forename: Camille
authors.initials: C
authors.lastname: Vigne
authors.forename: Jacques-Guy
authors.initials: JG
authors.lastname: Tebib
authors.forename: Yves
authors.initials: Y
authors.lastname: Pacheco
authors.forename: Fabienne
authors.initials: F
authors.lastname: Coury
mesh_terms: D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002648:Child; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011859:Radiography; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D012507:Sarcoidosis / Q000139:chemically induced / Q000000981:diagnostic imaging* / Q000628:therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept